电邮这篇文章 TROMBOEMBOLIYa LEGOChNOY ARTERII U PATsIENTA S ZABOLEVANIEM SPEKTRA OPTIKOMIELITA (OBSUZhDENIE KLINIChESKOGO NABLYuDENIYa I OBNOVLENNYKh KLINIChESKIKh REKOMENDATsIY ESC, 2019)
- 作者: Emelin AY.1, Yanishevskiy SN2, Skiba Y.B1, Andreev RV1, Polushin AY.3, Panov VA1, Puchek VD4, Buchin IM4
-
隶属关系:
- ВМедА им. С.М. Кирова
- НМИЦ им. В.А. Алмазова
- ПСПбГМУ им. акад. И.П. Павлова
- Филиал №3 3 ЦВКГ им. А.А. Вишневского
- 期: 卷 38, 编号 3 (Прил) (2019)
- 页面: 57-60
- 栏目: Articles
- URL: https://journals.rcsi.science/RMMArep/article/view/26134
- DOI: https://doi.org/10.17816/rmmar26134
- ID: 26134
如何引用文章
全文:
详细
作者简介
A Emelin
ВМедА им. С.М. КироваСанкт-Петербург
S Yanishevskiy
НМИЦ им. В.А. АлмазоваСанкт-Петербург
Ya Skiba
ВМедА им. С.М. КироваСанкт-Петербург
R Andreev
ВМедА им. С.М. КироваСанкт-Петербург
A Polushin
ПСПбГМУ им. акад. И.П. ПавловаСанкт-Петербург
V Panov
ВМедА им. С.М. КироваСанкт-Петербург
V Puchek
Филиал №3 3 ЦВКГ им. А.А. ВишневскогоОдинцово
I Buchin
Филиал №3 3 ЦВКГ им. А.А. ВишневскогоОдинцово
参考
- ESC Guidelines for the diagnosis and management of acute pulmonaryembolism developed in collaboration with the European Respiratory Society (ERS)// European Heart Journal. - 2019. - № 00. - 1-61.
- Anderson F.A. Jr., Spencer F.A. Risk factors for venous thromboembolism// Circulation. - 2003. - № 107. - I9-I16.
- Dada R. Acute jugular vein thrombosis during rituximab administration: Review of the lit // J. Oncol. Pharm. Practice. - 2014. - № - 1-5.
- Dresden S., Mitchell P., Rahimi L. Right ventricular dilatation on bedside echocardiography performed by emergency physicians aids in the diagnosis of pulmonary embolism // Ann. Emerg. Med. - 2014. - № 63. - 1624.
- Freund Y., Cachanado M., Aubry A. Effect of the pulmonary embolism rule-out criteria on subsequent thromboembolic events among low-risk emergency department patients: the PROPER randomized clinical trial // JAMA. - 2018. - № 319. - 559-566.
- Kline J.A., Mitchell A.M., Kabrhel C. Clinical criteria to prevent unnecessary diagnostic testing in emergency department patients with suspected pulmonary embolism // J. Thromb. Haemost. - 2004. - № 2. - 1247-1255.
- Marti C., John G., Konstantinides S. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and metaanalysis // Eur. Heart J. - 2015. - № 36. - 605-614.
- Meyer G, Vicaut E, Danays T. Fibrinolysis for patients with intermediate-risk pulmonary embolism // N. Engl. J. Med - № 2014. - № 370. - 1402-1411.
- Righini M, Van Es J., Den Exter P.L. Age-Adjusted D-Dimer Cutoff Levels to Rule Out Pulmonary Embolism: The ADJUST-PE Study // JAMA. - № 2014. - № 11(311). - 1117-1124.
- Righini M., Goehring C, Bounameaux H. Effects of age on the performance of common diagnostic tests for pulmonary embolism // Am. J. Med. 2000. - № 109. - 357-361.
- Senkus E., Jassem J. Cardiovascular effects of systemic cancer treatment// Cancer Treat Rev. - 2011. - № 4(37). - 300-311.
- Shichita T., Ito M., Yoshimura A. Post-ischemic inflammation regulates neural damage and protection// Front. Cell. Neurosci. - 2014. - № 14. - 319.
- Yang F., Wang,Z., Wei,X. NLRP3 deficiency ameliorates neurovascular damage in experimental ischemic stroke // J. Cereb. Blood Flow Metab. - № 34. - 660-667.
- Young A.M., Marshall A., Thirlwall J. Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial (SELECT-D) // J. Clin. Oncol. - 2018. 3- № 6. - 2017-2023.
补充文件
